Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 605 participants.
Also called NCT03551964
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 605 participants
- Sponsor
- Registry
-
NCT03551964 -
2018-002161-19
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia, France, Germany, Poland, Slovakia
- Registry status
- Completed
Technical summary
Registry record NCT03551964. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-01 (actual); primary completion 2024-02-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction
- Acronym
- DAPT-SHOCK-AMI
- Condition
- Acute Myocardial Infarction
- Condition
- Cardiogenic Shock
- Intervention (Drug)
- Cangrelor
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Faculty Hospital Kralovske Vinohrady
- Collaborator
- Charles University, Czech Republic
- Collaborator
- Masaryk University
- Collaborator
- Ministry of Health, Czech Republic
- Collaborator
- National Institute for Metabolic and Cardiovascular Disease Research
- Collaborator
- Institute of Hematology and Blood Transfusion, Czech Republic
- Collaborator
- BioVendor LM
Record details
- Record id
cardio:ct-nct03551964- Content hash
e78f1cdf803376486b04f22c565ed576c84902e0ffd6f2501717c6791a80fb84